"Simply put, the notion that [suspension orders] against distributors and manufacturers were a critical and frequently used tool before the Ensuring Patient Access Act passed and that the Act caused DEA's use of the tool to dry up is simply not correct," Mr. Hatch said.
"It's my view that the use of marijuana is detrimental, and we should not give encouragement in any way to it," he said. "And it represents a federal violation, which is in the law and it's subject to being enforced, and our priorities will have to be focused on all the things and challenges we face."
© Copyright 2017 The Washington Times, LLC
3600 New York Avenue NE, Washington, DC 20002